Qiming's portfolio company inventisbio lists on star market

Shanghai , july 24, 2022 /prnewswire/ -- qiming venture partners' portfolio company inventisbio (shse: 688382), a leading company in innovative drug development, today listed on the science and technology innovation board (the "star market") of the shanghai stock exchange. the issue price is cny 18.12 per share, representing a market cap of cny 10.419 billion.
BILI Ratings Summary
BILI Quant Ranking